Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript

1mon ago, source: InvestingChannel on MSN

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2023 Earnings Call Transcript March 27, 2024 Cellectar Biosciences, Inc. isn't ...

Cellectar Biosciences, Inc.

21d ago, source: CNN

Cellectar Biosciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse ...

Cellectar Biosciences, Inc. (NASDAQ:CLRB): When Will It Breakeven?

1mon ago, source: Yahoo Finance

We feel now is a pretty good time to analyse Cellectar Biosciences, Inc.'s (NASDAQ:CLRB) business as it appears the company may be on the cusp of a considerable accomplishment. Cellectar ...

Cellectar Biosciences Is An 'Attractive Acquisition Target' According To This Analyst - Here's Why

1mon ago, source: Hosted on MSN

Monday, Cellectar Biosciences Inc (NASDAQ:CLRB) announced that iopofosine I 131 combined with external beam radiation therapy (EBRT) was safe and tolerated in a SPORE Grant-supported investigator ...

Cellectar Biosciences Inc Registered Shs hosts conference call for investors

1mon ago, source: Business Insider

The company, Cellectar Biosciences Inc Registered Shs, is set to host investors and clients on a conference call on 3/27/2024 7:06:17 AM. The call comes after the company's earnings, which are set ...

Cellectar Biosciences, Inc. (CLRB) Q4 2023 Earnings Call Transcript

1mon ago, source: Seeking Alpha

Good morning. And welcome to Cellectar Biosciences 2023 Yearend Earnings Call. Today's call is being recorded. Before we begin, I would like to remind everyone that statements made during this cal ...

Cellectar Biosciences Inc (CLRB)

1d ago, source: Investing

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Cellectar Biosciences Inc CLRB

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cellectar Biosciences Inc CLRB

1mon ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cellectar Biosciences Inc (CLRB)

4d ago, source: Investing

Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Oil & Gas, Financials and Consumer Goods sectors led shares higher. At the ...

Cellectar Biosciences Inc.

1mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...